Latvia vs Portugal: Colon and rectum cancer screening coverage in Europe
Latvia
28.0%
in 2025
Portugal
16.1%
in 2024
Latvia rank
16th
Portugal rank
18th
Colon and rectum cancer screening coverage in Europe over time
- Latvia
- Portugal
How they compare
Latvia currently reports 28.0% against 16.1% in Portugal, a difference of 11.9%.
That makes Latvia's figure about 1.7 times Portugal's.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 16th and Portugal ranks 18th of 20 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 15.0% | 9.1% | 5.9% | Latvia |
| 2020s | 20.8% | 13.2% | 7.7% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher colon and rectum cancer screening coverage in europe, Latvia or Portugal?
- Latvia, at 28.0% against 16.1% in Portugal as of 2025.
- What is the difference in colon and rectum cancer screening coverage in europe between Latvia and Portugal?
- 11.9%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Portugal?
- 6 years are reported by both, from 2019 to 2024.
- How do Latvia and Portugal rank globally for colon and rectum cancer screening coverage in europe?
- Latvia ranks 16th and Portugal ranks 18th of 20 countries.
- Where does this data come from?
- Eurostat (2026) – with minor processing by Our World in Data, published as Colon and rectum cancer screening coverage in Europe. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of people aged 50 to 74 years who have been screened for colon and rectum cancer within the previous 2 years.